• by Bruce Carlson
  • December 10 2018


Smartphones and IVD: Early, But Getting There

Smartphones and IVD: Early, But Getting There

Development-stage projects - and a few products- mark the current field of smartphone in-vitro combinations, per Kalorama's new report.

  • by Aaron Hackle
  • December 6 2018


#BIOMEDevice2018: Kalorama Presents IVD Findings, Sums Up Best Opportunities in Testing, Biosensors and AI Discussed

#BIOMEDevice2018:  Kalorama Presents IVD Findings, Sums Up Best Opportunities in Testing, Biosensors and AI Discussed

At BIOMEDevice San Jose, leading device, testing, accessories and contract manufacturing firms presented their latest technology. Kalorama Information was there and presented the IVD market picture from its latest Worldwide Market for In Vitro Diagnostic Test report. Firms with new MI surgery, biosensor technologies and other products exhibited.

  • by Bruce Carlson
  • December 4 2018


Where Clinical Sequencing Is Now

Where Clinical Sequencing Is Now

Do NGS tests really offer useful insights beyond routine testing for targeted mutations? Are the high costs justified? Should everyone be sequenced? And what will happen when the price drops seriously? We discuss these topics in this article.

  • by Bruce Carlson
  • November 30 2018
  • HIV
  • IVD


The Latest Developments in HIV Diagnostic Testing

The Latest Developments in HIV Diagnostic Testing

HIV remains a deadly disease, but fortunately, in vitro diagnostic solutions abound for its detection and treatment progress-tracking. From utilizing dentists, to making tests available on more analyzer systems, we track the developments in HIV IVD in this articlee. More information can be found in our Worldwide Market for In Vitro Diagnostics Tests, 11th Edition

  • by Bruce Carlson
  • November 26 2018


Kalorama To Present IVD Market Findings at BIOMEDevice

Kalorama To Present IVD Market Findings at BIOMEDevice

Direct to Consumer Testing, The Status of Point of Care, Novel Biomarkers, Wearables, AI and Robotics, New EU Regulations - Kalorama will speak to these point and present top-level findings from our 11th Edition Worldwide IVD Market Study at the meeting in San Jose, CA, Dec. 4-6.

  • by Bruce Carlson
  • November 15 2018


13 Interesting Developments at #MEDICA2018

13 Interesting Developments at #MEDICA2018

From cutting-edge diagnostic tests to combating fear of spiders, it's been an interesting week. As the MEDICA 2018 total healthcare tradeshow comes to a close in Dusseldorf Germany, , we take note of these developments.

  • by Bruce Carlson
  • November 12 2018
  • IVD


7 Things We're Excited About at MEDICA 2018

7 Things We're Excited About at MEDICA 2018

As the well-attended and prestigious medical tradeshow begins in Dusseldorf, here's seven things we are finding interest in. Many in our core areas of in vitro/in vivo diagnostics, but there are some interesting device therapies that can't be ignored. Watch for more developments as the meeting continues.

  • by Bruce Carlson
  • November 12 2018


Big Developments in DTC Testing Space

Big Developments in DTC Testing Space

Kalorama predicted a large DTC market back in 2016. Some of that was predicated on the expected growth of startups. But we also had our eye on large players. Now both LabCorp and Quest have made different moves towards the same direction: allowing the consumer to order tests.


18 Billion-Dollar Market for Precision Cancer Diagnostics

18 Billion-Dollar Market for Precision Cancer Diagnostics

The global volume of precision cancer diagnostic procedures is forecast to reach 970 million in 2023, up 5.1% annually from 2018. Several trends and factors will contribute to growth, according to a new report from Kalorama Information.

  • by Bruce Carlson
  • October 26 2018


Despite Gains Over Malaria Infections, Diagnostics Need Still Growing

Deaths from malaria have fallen steadily worldwide over the past 20 years due to intensive global investment in malaria prevention and treatment. The malaria mortality rate fell by 60 percent from 2000 to 2015 worldwide, while the incidence is estimated to have decreased by 37%, according to the World Health Organization (WHO).